Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

Status:
Terminated

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

The purpose of the study is to evaluate the efficacy and safety of three doses of HL 10 given at fixed time intervals compared to standard therapy

Phase 3

LEO Pharma